(ATXI) Avenue Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Avenue Therapeutics | (ATXI) share price targets
Complete technical analysis of Avenue Therapeutics (ATXI) by charts plus indicators, forecast predictions and share price targets for Avenue Therapeutics (ATXI)
Avenue Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-25 View latest technical analysis
10 day averaged volume of Avenue Therapeutics is 95540
Date | Daily Closing Price | Open | High | Low | Volume |
25 Fri Oct 2024 | 2.20 | 2.14 | 2.29 | 2.02 | 1.465 times |
24 Thu Oct 2024 | 2.02 | 2.09 | 2.14 | 2.00 | 0.331 times |
23 Wed Oct 2024 | 2.10 | 2.05 | 2.15 | 2.01 | 0.195 times |
22 Tue Oct 2024 | 2.11 | 2.00 | 2.11 | 1.94 | 0.414 times |
21 Mon Oct 2024 | 2.00 | 2.60 | 2.70 | 1.94 | 5.283 times |
18 Fri Oct 2024 | 2.11 | 2.01 | 2.17 | 1.99 | 0.282 times |
17 Thu Oct 2024 | 1.99 | 2.18 | 2.41 | 1.70 | 1.831 times |
16 Wed Oct 2024 | 2.12 | 2.12 | 2.26 | 2.12 | 0.575 times |
15 Tue Oct 2024 | 2.09 | 2.07 | 2.17 | 1.89 | 0.879 times |
14 Mon Oct 2024 | 2.03 | 2.09 | 2.09 | 2.00 | 0.138 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.3 or till 2.5. Use a stoploss of 2.12 and if this stock hits its stoploss, then it can fall down till 1.97
Share price targets for Avenue Therapeutics (ATXI)
Target Type | Value |
Downside Target | 1.70 |
Downside Target | 1.90 |
Downside Target | 1.94 |
Downside Target | 2.07 |
Upside Target | 2.21 |
Upside Target | 2.41 |
Upside Target | 2.55 |
Upside Target | 2.70 |
Upside Target | 3.07 |
Upside Target | 3.25 |
Upside Target | 3.54 |
Upside Target | 3.93 |
Upside Target | 3.98 |
Intraday share price targets for Avenue Therapeutics (ATXI)
Target Type | Value |
Downside Intraday Target | 1.86 |
Downside Intraday Target | 1.52 |
Upside Intraday Target | 2.62 |
Upside Intraday Target | 3.04 |
Upside Intraday Target | 2.28 |
Weekly technical analysis of Avenue Therapeutics (ATXI)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Fri Oct 2024 | 2.20 | 2.60 | 2.70 | 1.94 | 2.075 times |
18 Fri Oct 2024 | 2.11 | 2.09 | 2.41 | 1.70 | 2.782 times |
11 Fri Oct 2024 | 2.06 | 2.10 | 2.29 | 1.90 | 1.728 times |
04 Fri Oct 2024 | 2.08 | 2.50 | 2.55 | 2.07 | 0.404 times |
27 Fri Sep 2024 | 2.51 | 2.56 | 2.59 | 2.21 | 2.175 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Avenue Therapeutics (ATXI)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Fri Oct 2024 | 2.20 | 2.42 | 2.70 | 1.70 | 2.221 times |
30 Mon Sep 2024 | 2.49 | 2.75 | 3.54 | 2.21 | 0.981 times |
30 Fri Aug 2024 | 2.54 | 2.91 | 3.07 | 2.25 | 0.353 times |
31 Wed Jul 2024 | 2.80 | 3.57 | 3.93 | 2.57 | 3.41 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Avenue Therapeutics (ATXI)
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Avenue Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Avenue Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Avenue Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Avenue Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Avenue Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.05 and Avenue Therapeutics (ATXI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Avenue Therapeutics (ATXI) stock. Volume based technical analysis of Avenue Therapeutics (ATXI) stock is negative.
Avenue Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Avenue Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Avenue Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Avenue Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Avenue Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Avenue Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.05 and Avenue Therapeutics (ATXI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Avenue Therapeutics (ATXI) stock. Volume based technical analysis of Avenue Therapeutics (ATXI) stock is negative.
Avenue Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.